237 related articles for article (PubMed ID: 21700275)
1. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.
Raicevic G; Najar M; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Cell Immunol; 2011; 270(2):207-16. PubMed ID: 21700275
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
3. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
4. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.
Zhang YN; Lie PC; Wei X
Cytotherapy; 2009; 11(5):548-58. PubMed ID: 19657806
[TBL] [Abstract][Full Text] [Related]
6. Role of toll-like receptors on human adipose-derived stromal cells.
Hwa Cho H; Bae YC; Jung JS
Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
8. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells.
Raicevic G; Rouas R; Najar M; Stordeur P; Boufker HI; Bron D; Martiat P; Goldman M; Nevessignsky MT; Lagneaux L
Hum Immunol; 2010 Mar; 71(3):235-44. PubMed ID: 20034529
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources.
Najar M; Raicevic G; Boufker HI; Fayyad Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Cell Immunol; 2010; 264(2):171-9. PubMed ID: 20619400
[TBL] [Abstract][Full Text] [Related]
14. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.
Zhao Q; Ren H; Li X; Chen Z; Zhang X; Gong W; Liu Y; Pang T; Han ZC
Cytotherapy; 2009; 11(4):414-26. PubMed ID: 19513901
[TBL] [Abstract][Full Text] [Related]
16. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity.
Lei J; Wang Z; Hui D; Yu W; Zhou D; Xia W; Chen C; Zhang Q; Wang Z; Zhang Q; Xiang AP
Cell Immunol; 2011; 271(1):147-56. PubMed ID: 21757189
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
[TBL] [Abstract][Full Text] [Related]
19. Expansion of the human adipose-derived stromal vascular cell fraction yields a population of smooth muscle-like cells with markedly distinct phenotypic and functional properties relative to mesenchymal stem cells.
Basu J; Genheimer CW; Guthrie KI; Sangha N; Quinlan SF; Bruce AT; Reavis B; Halberstadt C; Ilagan RM; Ludlow JW
Tissue Eng Part C Methods; 2011 Aug; 17(8):843-60. PubMed ID: 21595545
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
Manca MF; Zwart I; Beo J; Palasingham R; Jen LS; Navarrete R; Girdlestone J; Navarrete CV
Cytotherapy; 2008; 10(1):54-68. PubMed ID: 18202975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
